Hangauer MJ, Viswanathan VS, Ryan MJ, et al. Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition. Nature. 2017;551(7679):247-250. doi:10.1038/nature24297
Publications
Xiong Y, Soumillon M, Wu J, et al. A Comparison of mRNA Sequencing with Random Primed and 3’-Directed Libraries. Sci Rep. 2017;7(1):14626. doi:10.1038/s41598-017-14892-x
Zillikens C, Demissie S, Hsu YH, et al. Erratum: Large meta-analysis of genome-wide association studies identifies five loci for lean body mass. Nat Commun. 2017;8(1):1414. doi:10.1038/s41467-017-01008-2
Sabatini DM. Twenty-five years of mTOR: Uncovering the link from nutrients to growth. Proc Natl Acad Sci U S A. 2017;114(45):11818-11825. doi:10.1073/pnas.1716173114
Islam M, Mohamed EH, Esa E, et al. Circulating cytokines and small molecules follow distinct expression patterns in acute myeloid leukaemia. Br J Cancer. 2017;117(10):1551-1556. doi:10.1038/bjc.2017.316
Stancu MC, van Roosmalen MJ, Renkens I, et al. Mapping and phasing of structural variation in patient genomes using nanopore sequencing. Nat Commun. 2017;8(1):1326. doi:10.1038/s41467-017-01343-4
Adalsteinsson VA, Ha G, Freeman SS, et al. Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors. Nat Commun. 2017;8(1):1324. doi:10.1038/s41467-017-00965-y
Feinberg K, Kolaj A, Wu C, et al. A neuroprotective agent that inactivates prodegenerative TrkA and preserves mitochondria. J Cell Biol. 2017;216(11):3655-3675. doi:10.1083/jcb.201705085
Merino J, Udler MS, Leong A, Meigs JB. A Decade of Genetic and Metabolomic Contributions to Type 2 Diabetes Risk Prediction. Curr Diab Rep. 2017;17(12):135. doi:10.1007/s11892-017-0958-0
Hecking T, Thiesler T, Schiller C, et al. Tumoral PD-L1 expression defines a subgroup of poor-prognosis vulvar carcinomas with non-viral etiology. Oncotarget. 2017;8(54):92890-92903. doi:10.18632/oncotarget.21641